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Lipid bilayerHydrophobic lung surfactant proteins B and C (SP-B and SP-C) are critical for normal respiration in vertebrates,
and each comprises speciﬁc structural attributes that enable the surface-tension-reducing ability of the lipid–
protein mixture in lung surfactant. The difﬁculty in obtaining pure SP-B and SP-C on a large scale has hindered
efforts to develop a non-animal-derived surfactant replacement therapy for respiratory distress. Although
peptide-based SP-C mimics exhibit similar activity to the natural protein, helical peptide-based mimics of SP-B
beneﬁt fromdimeric structures. To determine if in vitro surface activity improvements in amixed lipidﬁlm could
be garnered without creating a dimerized structural motif, a helical and cationic peptoid-based SP-B mimic was
modiﬁed by SP-C-likeN-terminus alkylationwith octadecylamine. “Hybridized”mono- and dialkylated peptoids
signiﬁcantly decreased the maximum surface tension of the lipid ﬁlm during cycling on the pulsating bubble
surfactometer relative to the unalkylated variant. Peptoids were localized in the ﬂuid phase of giant unilamellar
vesicle lipid bilayers, as has been described for SP-B and SP-C. Using Langmuir–Wilhelmy surface balance
epiﬂuorescence imaging (FM) and atomic force microscopy (AFM), only lipid-alkylated peptoid ﬁlms revealed
micro- and nanostructures closely resembling ﬁlms containing SP-B. AFM images of lipid-alkylated peptoid ﬁlms
showed gel condensed-phase domains surrounded by a distinct phase containing “nanosilo” structures believed
to enhance re-spreading of submonolayer material. N-terminus alkylationmay be a simple, effective method for
increasing lipid afﬁnity and surface activity of single-helix SP-B mimics.in mNm−1; SP-B, surfactant protein B; SP-C, surfactant pr
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Lung surfactant (LS) is a functional lipid–proteinmixture that coats
the interior surfaces of the vertebrate lung as a ﬁlm [1–4]. By reducing
surface tension (γ, mN m−1) throughout the respiration cycle, LS
minimizes the effort in breathing and stabilizes the alveolar network
against collapse. LS predominantly forms an air/liquid (a/l) interfacialmonolayer, but attached bi/multilayers are created as the ﬁlm surface
area is expanded and compressed. The composition of LS is primarily
lipid by weight (∼90% including cholesterol), but the surfactant
protein (SP) fraction (∼5–10%) is critical for biophysical functioning
[5,6]. The two hydrophobic proteins, SP-B and SP-C (∼1–3 wt.%
of natural LS), are lipid-associated and sustain the efﬁcacy of the
ﬁlm, promoting: (i) rapid a/l interfacial adsorption, (ii) attainment ofotein C; a/l, air/liquid; SRT, surfactant replacement therapy; IRDS,
f SP-B consisting of amino acids 1–25; dSP-B1–25, dimeric SP-B1–25;
1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-rac-(1-glycerol); PA,
LWSB, Langmuir–Wilhelmy surface balance; FM, epiﬂuorescence
e, (N)-(S)-(1-phenylethyl)glycine; Nocd, (N)-(octadecyl)glycine;
ylammonium salt; SPPS, solid phase peptide synthesis; RP-HPLC,
ALDI-TOF/MS, matrix-assisted laser desorption/ionization time of
rium/maximum/minimum surface tension in mN m−1; π, surface
ity, W300B James H. Clark Center, 318 Campus Drive, Stanford,
f Physics and Chemistry, University of Southern Denmark, 5230M
servoss@uark.edu (S.L. Seurynck-Servoss),
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interface throughout continuous respiratory cycles. SP-B and SP-C
interactionswith lipids are crucial for optimal surfactant activity [7–9],
as lipid-only ﬁlms exhibit inferior in vitro and in vivo characteristics
[10].
Surfactant replacement therapy (SRT) is the common clinical
practice of animal-derived, exogenous LS administration for the
treatment of infant respiratory distress syndrome (IRDS) [11]. SRTs
for acute respiratory distress syndrome (ARDS) do not yet exist
[12,13]. Although animal-derived SRTs have been efﬁcacious, con-
cerns with regard to possible zoonotic infection, and difﬁculties in
surfactant production, such as the expense of extraction and inherent
batch-to-batch variability, have spurred the research and develop-
ment of synthetic formulations [14–16]. However, without SP-B, SP-C,
or functional mimics thereof, these formulations will not match the
performance of current SRTs. Peptoids [17], or poly-N-substituted
glycines, have shown promise as functional mimics of SP-B and SP-C
[18–23], and offer the advantages over peptides of facile synthesis
[24], enhanced bioavailability and biostability through protease-
resistance, and a longer shelf life with low propensity for solution-
phase irreversible aggregation [25–28].
SP-B and SP-C peptide- and peptoid-based mimicry has involved
targeting speciﬁc structural attributes of each protein believed to
impart surface activity. SP-B is a net-cationic 79-residue monomer
with three intramolecular disulﬁde bonds, and one intermolecular
disulﬁde bond that homodimerizes SP-B in vivo [29–32]. Its
unresolved structure is believed to contain four or ﬁve amphipathic
helices, yielding an overall helical conformation [33]. To date, SP-B
mimics have frequently represented SP-B1–25, the surface-active,
amphipathic, and helical N-terminus of the protein [34–38]. Designed
sequences either exactly replicate or simplify [19,39] this segment,
and in the interest of mimicking SP-B's more complex structure,
dimerized versions of two amphipathic helices have been created
[40,41]. With its hinge-like, cationic, and amphipathic structure, SP-B
can be viewed as an interfacial lipid transporter and organizer,
transiently inserting into lipid layers through Coulombic and
hydrophobic interactions, and facilitating folding and re-spreading
of LS material at the a/l interface.
Human SP-C is a 35-residue, extremely hydrophobic proteinwith a
helix that closelymatches the length of a DPPC lipid bilayer [32,42]. Its
two adjacent cationic residues at positions 11 and 12 promote
Coulombic interactions with anionic lipid headgroups [43], while the
poly-valine helix and palmitoylation points 5 and 6 securely anchor it
to a lipid layer [44,45]. SP-C primarily contributes to regulating the
stability and viscosity [46] of the ﬁlm, and its structure has indicated
an ability to keep lipid bi/multilayers “attached” to the interfacial
layer, thus enhancing adsorptive properties and reducing the
minimum γ reached at end-expiration [47,48]. In fact, palmitoylated
SP-C facilitates multilayer formation over the de-palmitoylated
variant [47]. Synthesized [49–51] and recombinant [52,53] mimics
of SP-C have emulated the hydrophobic helical region and palmitoy-
lated properties of the protein with some success.
For these proteins that are difﬁcult and impractical to synthesize or
obtain in pure form on a large scale, the development of simpler
molecules that replicate select structural motifs is very attractive.
Peptoid-based mimics of both SP-B and SP-C have demonstrated good
surface activity by speciﬁc in vitro tests in a tri-component lipidmixture,
the Tanaka lipids (TL) [54], 1,2-dipalmitoyl-sn-glycero-3-phosphocho-
line (DPPC): 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-rac-(1-glyc-
erol) (POPG):palmitic acid (PA) 68:22:9 [wt] [18–23,55]. To combine
the attributes of these two proteins into a single mimic, and thus
potentially enhance performance, the effects on in vitro surface activity
of SP-C-like N-terminal mono- or di-alkylation of a helical, amphipathic
peptoid-based SP-B mimic [20] were investigated.
First, we present the structural characterization of all peptoid-
basedmimics by circular dichroism spectroscopy (CD) andultraviolet/visible (UV/Vis) spectroscopy. Then, the behavior of the peptoid
mimics in bi/multilayer mixed lipid systems was assessed, with static
and dynamic functional properties of mimics determined via
pulsating bubble surfactometry (PBS). Lipid–peptoid interactions
and phase segregation in lipid bilayers were then observed in giant
unilamellar vesicles (GUVs). Further insight into interfacial lipid–
peptoid monolayer behavior at the micro- and nanoscales was
afforded by Langmuir–Wilhelmy surface balance studies with FM
imaging (LWSB/FM), and atomic force microscopy (AFM). As the
equivalent bilayer surface pressure is believed to be ∼30 mNm−1
[56,57], the GUV bilayer technique complements studies involving FM
and AFM imaging of monolayer systems at similar surface pressures.
We report that the activities of the alkylated peptoids compare
favorably to those of porcine-derived SP-B and the N-terminal
fragment SP-B1–25, and postulate that alkylation substantially
improves surface activity by increasing lipid afﬁnity, enhancing lipid
ﬁlm insertion, and contributing to the formation of submonolayer
structures that aid in re-spreading lipid material at the a/l interface.
2. Materials and methods
2.1. Materials
Peptide andpeptoid synthesis reagents and supplieswerepurchased
from Applied Biosystems (ABI) (Foster City, CA) and Sigma-Aldrich
(Milwaukee, WI). Fmoc-protected amino acids and resins were
obtained fromEMDBiosciences (NovaBiochem, SanDiego, CA). Primary
amines (highest purity and enantiomeric excess available, Fig. 1), di-
tert-butyl dicarbonate (Boc), and palmitic acid (PA) were purchased
fromAldrich. All salts, and solvents acetonitrile, 2-propanol, chloroform,
methanol, and triﬂuoroacetic acid (TFA), HPLC grade or better, were
obtained from Fisher Scientiﬁc (Pittsburgh, PA). DPPC and POPG were
purchased fromAvanti Polar Lipids (Alabaster, AL) and used as received.
Texas Red®, 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine,
triethylammoni-um salt (TR-DHPE) and 2-(4,4-diﬂuoro-5,7-dimethyl-
4-bora-3a,4a-diaza-s-indacene-3-penta-noyl)-1-hexadecanoyl-sngly-
cero-2-phosphocho-line (Bodipy-PC) were obtained from Molecular
Probes (Eugene, OR), Alexa Fluor® 633 carboxylic acid, succinimidyl
ester from Invitrogen (Carlsbad, CA), and 1,1′-dioctadecyl-3,3,3′,3′-
tetramethylindodicarbocyanine perchlorate [DiIC18(5)] from Aldrich.
All chemicalswere usedwithout further puriﬁcation.WaterwasMilli-Q
18.2 mΩ cm quality.
2.2. Protein extraction, and peptide and peptoid synthesis and
puriﬁcation
Porcine SP-B was a gift from Prof. Jesús Pérez-Gil (Madrid, Spain),
isolated from minced porcine lungs as described previously [58]. The
modiﬁed peptide SP-B1–25 (Cys8,11 → Ala) [34,35] was synthesized
by standard solid-phase peptide synthesis (SPPS) [59] Fmoc chemis-
try on a 0.25 mmol scale using preloadedWang resin and an ABI 433A
automated peptide synthesizer (Supplementary Material, Table 1SM).
Peptoids were synthesized by the submonomer method [24] using
Rink amide resin on a 0.25 mmol scale, and an ABI 433A, with Boc
protection of N-(4-aminobutyl)glycine (NLys) (Fig. 1, Table 1SM). All
molecules were puriﬁed according to standard reverse-phase high
performance liquid chromatography (RP-HPLC) puriﬁcation techni-
ques (see SM). Final purities were conﬁrmed to be N97% by analytical
RP-HPLC and molecular weights were obtained by either electrospray
ionization mass spectrometry (ESI/MS) or matrix-assisted laser
desorption/ionization time of ﬂight mass spectrometry (MALDI-
TOF/MS). Both monomer (∼8794 Da) and dimer (∼17,588 Da) peak
intensities were observed in the MALDI-TOF/MS spectra for porcine-
derived SP-B (data not shown).
Fluorescent SP-B1–25 and peptoids for GUV studies were prepared
after synthesis and puriﬁcation by adding a glycine residue spacer to
Fig. 1. Peptoid 3 chemical structure and side chain structures. Peptoid 3 is the dialkylated variant of Peptoid 1 [20]. For all peptoid sequences and molecular weights, see the
Supplementary Material (Table 1SM).
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described previously [60]. Brieﬂy, ∼2 mg of each molecule dissolved
in a small amount of methanol was pH-adjusted to 7.0 by adding
50 mM triethylamine in methanol. The pH adjustment was necessary
to deprotonate the N-terminus amine, allowing for preferential
labeling. Each solution was then incubated in darkness at 4 °C with
constant stirring in the presence of the dye Alexa Fluor® 633
carboxylic acid, succinimidyl ester for 12 h, at which point 2 M HCl
was added until the pH wasb3. Unreacted probe was immediately
separated from the products by RP-HPLC. The labeled products were
lyophilized to remove excess solvent. ESI/MS of the labeled species
showed that the predominant peak was singly labeled.
2.3. Spectroscopy
Circular dichroism (CD) measurements were acquired on a Jasco J-
715 spectropolarimeter (Easton, MD) in a cylindrical quartz cuvette
(Hellma model 121-QS, Forest Hills, NY) with a scan rate of
100 nmmin−1, 0.02 cm path length, 0.2 nm data pitch, 1 nm band-
with, 2 s response, and 100 mdeg sensitivity, from wavelengths (λ)
280–192 nm. Samples were dissolved in methanol from lyophilized
powder to ∼15, 30, or 60 μM, calculated from averaged dry weight
measurements, and run at room temperature. Alexa-labeled mimics
were run at ∼0.1 mg mL−1. Each presented CD spectrum represents
the average of 40 accumulations. Ultraviolet/Visible (UV/Vis)
measurements were recorded in double beam mode on a Cary 500
UV–VIS–NIR spectrophotometer (Varian, Palo Alto, CA) using quartz
cuvettes (Varian), from λ 990–190 nm with a scanning rate of
20 nmmin−1 and data interval collection of 1 nm. Samples were
dissolved in methanol from lyophilized powder to ∼5, 50, or 100 μM
and run at room temperature. Each UV/Vis sample was run twice.
2.4. Surfactant sample preparation
The lipids DPPC, POPG, and PA were individually dissolved in a
chloroform/methanol solution (3/1 [v/v]) to ∼2 or 4 mg mL−1, as
calculated from averaged dry weight measurements. Single-lipid
solutions were then combined by volume at the ratio of DPPC:POPG:
PA, 68:22:9 [wt:wt:wt] and to ∼2 mg lipid mL−1. This well-
characterized lipid formulation, the Tanaka Lipids (TL) [54], isconsidered an adequate mimic of the non-protein (lipid) fraction of
LS. The peptides and peptoidswere individually dissolved inmethanol
from a lyophilized powder to ∼1–2 mg mL−1, as calculated from
averaged dry weight measurements. For the PBS, LWSB/FM, and AFM
studies, the peptides and peptoids were added to the TL lipid solution
at ∼2 mol% (∼11–12 absolute wt.%, see Table 1SM), and the ﬁnal
solution was diluted to ∼1 mg lipid mL−1. For comparative purposes,
the inclusion of peptide/peptoid at ∼2 mol% corresponds to ∼10 wt.%
SP-B1–25 relative to the total lipid content (∼9 absolute wt.%). Porcine
SP-B was dissolved in chloroform/methanol and added to the TL
solution at ∼1 mol%, corresponding to roughly ∼10 wt.% of the
monomer unit relative to the total lipid content (∼9 absolute wt.%).
The concentration of ∼10 wt.% was selected for consistency with
previous reports and to ensure comparability for all studied lipid–
peptoid formulations [19–21,61–64]. GUV studies were performed
with either ∼5 or 10 absolute wt.% of peptide/toid. For PBS and LWSB
experiments, the standard deviation of the mean (σ) was reported.
2.5. Pulsating bubble surfactometry
A commercial pulsating bubble surfactometry (PBS) instrument
(General Transco, Largo, FL), modiﬁed with a direct, real-time imaging
system, which has been previously described and validated in detail
[63], was utilized to obtain both static-mode and dynamic-mode data.
Samples were dried to a pellet from chloroform/methanol 3/1 [v/v]
using a DNA 120 speedvac (Thermo Electron, Holbrook, NY). The pellet
was resuspended in buffer (150 mM NaCl, 10 mM HEPES, 5 mM CaCl2,
pH 6.9) to ∼70 μL at ∼1 mg lipid mL−1. Samples were mixed with a
pipette 20 times, sonicated with a Fisher Model 60 probe sonicator for
two 15-second spurts, and then mixed again 20 times to form a
dispersed suspension. Samples were then loaded into a small plastic
sample chamber (General Transco) using a modiﬁed leak-free meth-
odology [63,65]. The sample chamber was placed in the instrument
water bath at room temperature or 37 °C. A bubble with a radius
of ∼0.4 mm was formed, and surface area (SA) was monitored
throughout the experiment (bubble size gradually increased in both
data collection modes, but had a negligible effect on γ).
Static-mode adsorption data were collected for 20 min, where the
suspension was allowed to adsorb to the bubble surface over time.
Adsorption data were smooth ﬁt to a curve in the Kaleidagraph®
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output of this function then had a geometric weight applied to the
current point and ± 10% of the data range to arrive at the smoothed
curve. Dynamic-mode data were then subsequently obtained for each
sample at the adult respiratory cycle frequency of 20 cycles per
minute (cpm) for 10 min, with a ∼50% reduction in surface area per
pulsation cycle (standard for the PBS instrument). PBS experiments
were repeated six times for unlabeled ﬁlms at 37 °C, and three times
for ﬂuorescently labeled ﬁlms at 37 °C and all ﬁlms at room
temperature. Representative PBS loops are presented at 5 min of
cycling, and indicate clockwise bubble expansion from left to right.
Percent compression is deﬁned here as 100⁎ [(SAmax−SA20)/
(SAmax)], where SAmax was the maximum SA value at expansion,
and SA20 was the SA at which γ ﬁrst reaches 20mNm−1 upon
compression.
2.6. Giant unilamellar vesicles studies
Giant unilamellar vesicles (GUVs) were prepared as previously
described [66]. Initially, ∼0.2 mol% of the ﬂuorescently labeled lipid
DiIC18(5) and either ∼0.2 mol% Bodipy-PC (for lipids-only GUVs) or
∼5 or 10 absolute wt.% of peptide or peptoid (for lipid–peptoid GUVs)
were dissolved in methanol and added to a ∼0.5 mg mL−1 DPPC:
POPG:PA68:22:9 [wt] lipidmixture in chloroform/methanol 3/1 [v/v].
The GUVswere produced using an electroformationmethod described
by Angelova and Dimitrov [67,68]. Brieﬂy, 3 µL of the labeled lipid–
peptoid/tide solution was spread onto a Pt wire electrode surface in
the samplewell of a specially designed Teﬂon chamber [69],whichwas
placed under vacuum in darkness for ≥1.5 h for trace solvent
evaporation. Then, ∼500 mL of a 200 mOsM sucrose solution were
added to each sample well and a low frequency AC ﬁeld of 10 Hz and
1.5 V amplitude was applied for 1.5 h using a function generator (Van
Draper Digimess Fg 100, Stenson, Derby, UK). A circulating water bath
was used to maintain the sample chamber temperature at 60 °C,
sufﬁciently above the gel/ﬂuid transition temperature. The GUVswere
thenharvestedwith a pipette and transferred to a plastic vial. Just prior
to imaging, ∼50 μL aliquots of the harvested GUV suspension were
each transferred into a single well of an eight-well cell containing
∼200 μL equi-osmolar glucose culture plate (Lab-Tek Brand Products,
Naperville, IL). The GUVs were then imaged at room temperature,
21 °C, using an inverted confocal microscope (Zeiss LSM 510 META).
The excitation wavelengths were λ∼543 nm for the DiIC18(5) and
∼633 nm for the Alexa Fluor® 663 labeled compounds.
2.7. Langmuir–Wilhelmy surface balance and epiﬂuorescence
microscopy studies
Surface pressure (π)-molecular area (A) isotherms were obtained
using a custom-built Langmuir–Wilhelmy surface balance (LWSB),
where the instrument and method have been previously described
[19–22]. The trough was ﬁlled with ∼300 mL of aqueous buffer
(150 mM NaCl, 10 mM HEPES, 5 mM CaCl2, pH 6.9) and heated to 25
or 37 °C. A Wilhelmy plate (Reigler & Kirstein GMBH, Berlin, Germany)
was used to monitor surface pressure and calibrated in buffer before
each run. Each sample was spread at the a/l interface from a 3/1
chloroform/methanol solution [v/v] using a glass syringe and allowed
to equilibrate for 5–10 min. The barriers were then compressed,
expanded, and compressed again at a rate of 30 mmmin−1. Isotherm
measurements were repeated at least six times for each sample.
To record epiﬂuorescencemicroscopy (FM) images, a NikonMM40
compact microscope stand with a 100 W mercury lamp (Tokyo,
Japan) was used in conjunction with the LWSB. Epiﬂuorescence was
detected by a Dage-MTI three-chip color camera (Dage-MTI, Michigan
City, IN) in conjunctionwith a generation II intensiﬁer (Fryer, Huntley,
IL). Samples were spiked with ∼0.5 mol% TR-DHPE, a ﬂuorescently
headgroup-labeled lipid, for detection. Isotherm features remainedunchanged after TR-DHPE addition, and presumably, ﬁlmmorphology
was also unchanged by the presence of TR-DHPE at these concentra-
tions. FM images were acquired directly from the compressed ﬁlm on
the a/l interface. Experiments were conducted exactly as the LWSB
studies of unspiked ﬁlms, with the exception that barrier speed was
reduced to 5 mmmin−1, and experiments were repeated three times.
Average liquid-condensed (LC) domain sizes were calculated using
ImageJ software (National Institutes of Health, Bethesda, Maryland).
2.8. Atomic force microscopy
Atomic force microscopy (AFM) results were obtained on solid-
supported lipid and lipid–peptoid/tide Langmuir–Blodgett ﬁlms,
wherein an a/l interfacial ﬁlm held at constant surface pressure was
transferred onto a mica substrate. Monolayers were prepared by
spreading the lipid and lipid–peptoid/tide solutions (chloroform/
methanol 3/1 [v/v]) onto an aqueous-buffered subphase (150 mM
NaCl and 5 mM Tris, pH 7) maintained at 25 °C in a specially designed,
continuous ribbon NIMA Langmuir–Blodgett trough (NIMA Technol-
ogy, UK) at minimum surface pressure (∼0–1mNm−1). After 10 min
of ﬁlm equilibration, themonolayer was compressed at 50 cm2 min−1
until the desired surface pressure was reached (∼30 or 60mN m−1)
(full compression isotherms are available in Fig. 7SM). The ﬁlm was
again equilibrated for 5 min at constant pressure. Then, a previously
immersed, freshly cleaved muscovite mica substrate (Plano, Wetzlar,
Germany) was vertically lifted out of the subphase at a speed of
10 mmmin−1 to generate the solid-supported ﬁlm. The deposition
was complete when the substrate was completely removed from the
aqueous subphase and exposed to air. The Langmuir–Blodgettﬁlmwas
subsequently dried overnight in a clean, sealed compartment to avoid
sample contamination. Topographical images were obtained with an
atomic force microscope (JPK NanoWizard, JPK Instruments, Berlin,
Germany) using the air-tapping mode and Silicon-SPM cantilevers
(Nanosensors, NanoWorld AG) operating at their resonance frequency
(76–263 kHz) with a force constant between ∼1.2 and 29 N m−1
(nominal). The scan rate was ∼1 Hz for all experiments.
3. Results
3.1. Mimic design rationale
We aimed to mimic the helicity, hydrophobicity, and cationic facial
amphipathicity of the surface-active N-terminus fragment of SP-B, SP-
B1–25, all while comprising a minimal number of different side chains,
emulating KL4 (a simpliﬁed peptide that generically adopts SP-B's
overall charge patterning [39]). Minimizing the number of distinct side
chains provides the advantages of ease of synthesis and reduced
production costs. The design, synthesis, and in vitro surface activity
testing of previous single-helix peptoid-based SP-B mimics have been
described [19]. The in vitro surface activities of these peptoids in a DPPC:
POPG:PA lipid ﬁlm were as good as those of SP-B1–25 and KL4 [19].
Particularly, the inclusion of bulky, chiral, and aromatic side chains
(Nspe, Phe-like, Fig. 1, Table 1SM) increased surfactant activity relative
to sequences containing chiral, aliphatic side chains (Nssb, Ile-like).
A subsequent study described improved in vitro surface activity
after including an end-on attachment of an insertion region at the
N-terminus (Fig. 1) [20], meant to mimic SP-B1–9, the ﬂexible strand
fragment considered critical for γ-reducing ability [70]. Although the
hydrophobic and helical nature of the peptoid segment contrasted
with the proline-containing peptide insertion region (prolines
incorporate well into peptoid helices), the similarity between the
sequences resided in the eight-residue length and the high proportion
of ring-containing side chains in the peptide (Phe, Pro, Tyr, and Trp)
known to facilitate lipid insertion [20,70].
In parallel, our development of peptoid-based SP-C mimics is
ongoing [18,22], and current investigations revealed that N-terminus
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mimics (submitted manuscript [71]). Therefore, in the interest of
uniquely combining the functionalities of, or “hybridizing,” SP-B and
SP-C into a single peptoid to enhance in vitro performance, the most
promising peptoid-based SP-B mimic, 1, was mono- (2) and
dialkylated (3) with N-(octadecyl)glycine (Nocd, or octadecylamine)
at the N-terminus (Fig. 1, Table 1SM), and subsequent effects on
activity were explored by multiple in vitro tests. Note that the Nocd
submonomer is incorporated into the peptoid sequence easily using
the standard submonomer synthesis method [24].3.2. Spectroscopy
3.2.1. Circular dichroism spectroscopy
CD spectra were recorded to assess solution-phase secondary
structure for all peptoids at ∼60 μM in methanol, a lipid-mimetic
environment, at room temperature (Fig. 2A). SP-B and its fragments are
helical in solution, and the peptoids were designed to retain this
characteristic in hopes of emulating the amphipathicity of the protein.
All peptoids yielded spectra characteristic of aromatic peptoid helices,
with a global maximum at a wavelength (λ) of ∼193 nm, a minimum
at ∼205 nm, and a global minimum at ∼221 nm [26]. The spectra of 2
and 3 directly overlaid one another (Fig. 2A). A noticeable increase in
extent of helicity was observed upon alkylation in 2 and 3 relative to 1Fig. 2. CD and UV/Vis spectra of peptoids in methanol at room temperature. (A) CD
spectra for peptoids in methanol at 60 μM. λ is Wavelength (nm) and θ is Per Residue
Molar Ellipticity (deg cm2 dmol−1). 1 (black), 2 (red), 3 (blue). (B) UV/Vis spectra for
peptoids in methanol at 100 μM. Abs is Absorbance in arbitrary units. 1 (black, circles),
2 (red, squares), 3 (blue, diamonds).[20], particularly at the global maximum and global minimum λ
(Fig. 2A). The presence and magnitude of this effect was retained over
time in solution and at concentrations as low as ∼30 and ∼15 μM
(Fig. 1SM, Panels A–B), diminishing the likelihood of a concentration-
dependent associative effect. In addition, the helical nature of the SP-B1–25
peptide (previously published) [19,20] and peptoids 1 and 3was retained
after ﬂuorescent labeling with Alexa Fluor® 633 (Fig. 1SM, Panel C).
3.2.2. Ultraviolet/visible spectroscopy
To further explore the observed increase in extent of helicity by CD
after peptoid alkylation, UV/Vis spectra were collected in methanol at
room temperature, at concentrations of ∼5, 50 and 100 μM (Fig. 2B
and Fig. 2SM, Panel B). At all three concentrations, the spectra for 2
and 3 exhibited similar features that were different from that of 1. At λ
∼260 nm, which surveys the environment of aromatic functional
groups, the peak shapewas signiﬁcantly broader for 1 than 2 and 3, and
an increased absorbance was observed in the light scattering range of λ
300–350 nm for 1 relative to 2 and 3. Note that at each concentration,
the λ ∼260 nm absorbance for the peptoids decreased signiﬁcantly in
the order of 1N3N2 (Fig. 2B and Fig. 2SM, Panel B). These spectral
signature changes and drop in absorption post-alkylation indicate
hydrophobic interactions between the alkylated hydrocarbon chains
and aromatic interactions between the amphipathic, Nspe-containing
helices. In the peptide bond-absorbing region, λ ∼220 nm, 2 and 3
demonstratedmuch higher absorbance than 1, indicative of a structural
change in backbone amide group positioning (Fig. 2SM, Panel A). There
was no evidence of micellar formation (turbidity) in the λ∼590 nm
region for all concentrations tested (Fig. 2SM, Panel C).
3.3. Pulsating bubble surfactometry
3.3.1. Static-bubble mode
A functional lung surfactant must have an immediate, γ-reducing
effect at an a/l interface in order to properly enable respiration. The
adsorptive properties (γ vs. time) of lipid–peptoid suspensions at the
interface of a ∼0.4 mm radius bubble were thus monitored using the
PBS at 37 °C in static-mode (Fig. 3A, representative traces). Mean
γ±σ at selected time intervals are presented in Table 1. For instance,
Infasurf®, a clinically administered SRT derived from natural LS,
typically reaches a low equilibrium γ (γeq) of ∼23mNm−1 at the a/
l interface within 1–2 min on the PBS [63]. The peptoids' activities in a
DPPC:POPG:PA 68:22:9 [wt] Tanaka lipid (TL) ﬁlm were compared to
those of porcine-derived SP-B and SP-B1–25 in the same lipid mixture.
The TL+SP-B suspension adsorbed toγ of∼25mNm−1 in less than
5 min, and attained aγeq of∼24mNm−1 (Fig. 3A, Table 1). The seeming
inability of TL+SP-B to reach γeq of ∼24mNm−1 within 1 min is likely
related to either i) the lipid composition, which only partly mimics the
total lipid composition of natural LS, or ii) possible localized protein
aggregation due to the high content (∼10 wt.%) of SP-B [72]. In stark
contrast, TL adsorbed very slowly, requiring 20 min to reach a high γeq
of ∼53 mNm−1. The TL+SP-B1–25 ﬁlm (trace not shown, previously
published [19–21]) exhibited less rapid adsorption with an γeq of
∼36 mN m−1 (Table 1). All lipid–peptoid mixtures dramatically
enhanced adsorption relative to TL. As suggested by the increased σ
of TL+1 upuntil 10 min (Table 1), thisﬁlm exhibited variable and slow
adsorption rates relative to TL+2 and TL+3 [20]. Mono- and
dialkylation improved the adsorption rate of the lipid–peptoid ﬁlms,
where TL+2 andTL+3 reached∼27mNm−1 before∼2.5 min (Fig. 3A,
Table 1). However, these ﬁlms adsorbed to slightly higher γeq's of ∼25–
26mNm−1, while TL+1 attained a γeq of ∼23mNm−1.
3.3.2. Dynamic-bubble mode
The maintenance of good surfactant activity during the dynamic
changes in volume or ﬁlm surface area at the a/l interface was
assessed via bubble pulsation in PBS dynamic-mode. This method
permits a simpliﬁed evaluation of in vitro dynamic ﬁlm behavior,
Fig. 3. PBS static- (A) and dynamic-mode (B) data for lipid–peptoid aqueous buffer suspensions at 37 °C. Tanaka lipids alone (TL, black, circles), TL+1 (red, open circles), TL+2
(blue, triangles), TL+3 (orange, diamonds), and TL+SP-B (purple, vertical crosses) in aqueous buffer (150 mMNaCl, 10 mMHEPES, 5 mM CaCl2, pH 6.9) at 37 °C. See Tables 1 and 2
for static- and dynamic-mode data, respectively. Data presented are representative traces, where in dynamic-mode (B), traces are after 5 min of cycling at the approximate adult
respiratory rate of 20 cycles per minute (cpm), and bubble expansion is clockwise from left to right.
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near-zero minimum γ (γmax and γmin, respectively) [63]. The
γ-surface area (SA) data loops in Fig. 3B for each lipid–peptoid
mixture are one representative pulsation cycle at 20 cycles per minute
(cpm) after 5 min at 37 °C, with bubble expansion in a clockwise loop
direction. The mean γmax/min±σ at selected time intervals are
presented in Table 2.
The absence of low-γ data in some loops results from the inability
of the image analysis system to trace the bubble shape in this regime.
The highly compressed state of the ﬁlm that enables it to reach low γ
often causes signiﬁcant bubble shape deformation that inhibits bubble
tracing to obtain SA or employing the ellipsoidal Laplace equation to
calculate γ [63]. However, lipid–peptoid ﬁlms that did not reach
b1mNm−1 could be accurately traced to the minimum surface
tension reached and never exhibited signiﬁcant bubble deformation.
Visual, real-time bubble inspection conﬁrmed that signiﬁcant bubble
deformation occurred and that γ reached near-zero in these ﬁlms.
Although bubble size varied slightly for every experiment, small
differences in x-axis positioning (SA) had a negligible effect on γ.
The PBS cycling loop for clinically used Infasurf® has a γmax
of ∼35 mNm−1 and a γmin near zero [63]. This near-zero γmin should
appear upon cycling commencement and remain indeﬁnitely with
minimal SA compression to reach near-zero γ. Similarly, the TL+SP-B
ﬁlm exhibited a γmax of ∼36mNm−1 and near-zero γmin, with ∼21%Table 1
Summary of PBS adsorption data at 37 °C in static-mode at selected time intervals.
Dried lipid–peptoid ﬁlms (lipid ∼1 mg mL−1) were resuspended in aqueous buffer
(150 mMNaCl, 10 mMHEPES, 5 mM CaCl2, pH 6.9) and allowed to adsorb to the bubble
interface over time. The standard deviation of the mean (σ) is reported.
Film γa 1 min γ 2.5 min γ 5 min γ 10 min γeq
20 min
Avg σ Avg σ Avg σ Avg σ Avg σ
TLb 61.3 1.9 59.0 1.8 56.8 1.8 54.6 1.8 52.6 1.7
TL+1c 33.9 5.8 29.4 4.6 26.5 3.9 23.9 1.2 23.2 0.9
TL+2 28.6 1.1 27.1 0.5 26.3 0.6 25.5 0.7 25.3 0.9
TL+3 27.8 0.9 27.0 0.8 26.5 0.8 25.8 0.9 25.6 1.4
TL+SP-Bd 33.5 2.4 28.3 1.9 25.7 0.8 24.6 0.9 24.4 1.1
TL+SP-B1–25 40.5 1.2 39.4 1.9 37.9 1.2 36.8 1.0 35.6 1.3
a Mean surface tension in mN m−1.
b Tanaka lipid mixture, DPPC:POPG:PA 68:22:9 [wt].
c Mimics added at ∼2 mol%, equivalent to ∼10 wt.% SP-B1–25 peptide relative to the
total lipid content.
d Porcine SP-B added at ∼1 mol% based on monomer composition, roughly
equivalent to ∼10 wt.% relative to the total lipid content.SA compression to reach 20mNm−1 (Fig. 3B, Table 2). The TL ﬁlm
demonstrated very poor surfactant activity characteristics, with a high
γmax of ∼63mNm−1, a γmin of ∼12mNm−1, and ∼49% compression.
The addition of unalkylated 1 to the lipid ﬁlm reduced the γmax
to ∼46 mN m−1 and the γmin to near-zero immediately upon
pulsation. The percent SA compression was also reduced to ∼26%.
The γmax and percent SA compression further decreased upon mono-
(2), and then dialkylation (3), of the peptoid helix, with 3 reaching a
γmax matching that of Infasurf® (∼35mNm−1), and attaining a
surprisingly low 12% SA compression to reach 20mNm−1 (Table 2).
Also of note are the differences in bubble shape between TL+SP-B
and the TL+peptoid ﬁlms, where the loop hysteresis wasmuch larger
for peptoid-containing ﬁlms (Fig. 3B). The signiﬁcance of a large
degree of hysteresis has not yet been established, but in lipid–peptoid
ﬁlms generally correlates with less compression to reach near-zero γ
[19,20].
In peptoids, the improved PBS activity could be associatedwith the
amount of material attached to the monolayer and therefore available
for reincorporation during the re-expansion process (inhalation) as
ﬁlm surface area increases. Structurally, this material would likely
form bilayers, and therefore, we have employed GUVs to observe the
lipid phase segregation behavior and speciﬁc lipid–peptoid interac-
tions in these lipid bilayer vesicles.
3.4. Giant unilamellar vesicle studies
The lipid phase segregation pattern in the bilayer plane was
imaged in GUVs comprising TL, doped with ∼0.2 mol% of the labeled
lipid DiIC18(5) and either ∼0.2 mol% of the labeled lipid BODIPY-PC
(for TL-only GUVs), or ∼10 absolute wt.% of ﬂuorescently labeled SP-
B1–25, 1, or 3, (for TL+peptoid GUVs) at room temperature (Fig. 4).
The labeled lipids DiIC18(5) and BODIPY-PC were bulky and
preferentially excluded from the well-ordered lipid phases (dark),
and distributed into the ﬂuid phase (bright), providing phase
coexistence contrast in the GUV images [73]. Native SP-B was
previously studied using GUVs in a different lipid mixture [66],
where it was determined that, in a ﬂuid ordered/ﬂuid disordered
two-phase coexistence, SP-B co-localized with SP-C in the disordered
phase. Therefore, the preferential partitioning of our mimics and SP-
B1–25 in free-standing TL lipid bilayers is of comparative interest for
this particular study.
In all images, the lipid probes resided in the ﬂuid phase. Based on
the apparent partitioning of the lipophilic probes used [73], the
domain shape, and the saturated/unsaturated chain properties of the
Table 2
PBS dynamic-mode cycling data at 37 °C at selected time intervals. Dried lipid–peptoid ﬁlms (lipid ∼1 mg mL−1) were resuspended in aqueous buffer (150 mMNaCl, 10 mMHEPES,
5 mM CaCl2, pH 6.9), wherein a bubble was pulsed at 20 cpm. The standard deviation of the mean (σ) is reported.
Film 1 min 5 min 10 min %
comp
b
σ
γamax σ γmin σ γmax σ γmin σ γmax σ γmin σ
TLc 64.3 2.8 12.3 2.4 63.3 2.4 12.3 1.8 62.3 2.4 11.6 3.1 48.7 2.9
TL+1d 44.9 1.2 b1f – 46.1 1.0 b1 – 46.1 1.9 b1 – 26.4 3.6
TL+2 38.6 2.4 b1 – 39.7 2.8 b1 – 39.8 2.6 b1 – 16.6 3.5
TL+3 34.9 1.6 b1 – 35.2 2.0 b1 – 35.0 2.2 b1 – 12.2 3.8
TL+SP-Be 36.5 1.1 b1 – 35.8 1.3 b1 – 36.0 1.9 b1 – 21.0 2.6
TL+SP-B1–25 49.6 0.5 b1 – 49.9 0.4 b1 – 49.8 0.7 b1 – 33.2 2.7
a Mean surface tension in mN m−1.
b Percent compression is deﬁned here as 100⁎ [(SAmax−SA20)/(SAmax)], where SAmax was the maximum surface area (SA) at expansion, and SA20 was the SA at which γ ﬁrst
reaches 20 mN m−1 upon compression.
c Tanaka lipid mixture, DPPC:POPG:PA 68:22:9 [wt].
d Mimics added at ∼2 mol%, equivalent to ∼10 wt.% SP-B1–25 peptide relative to the total lipid content.
e Porcine SP-B added at ∼1 mol% based on monomer composition, roughly equivalent to ∼10 wt.% relative to the total lipid content.
f No σ values are available for “b1” table entries.
Fig. 4. Lateral distribution of peptide-/peptoid-based mimics in DPPC:POPG:PA giant
unilamellar vesicles (GUVs) at room temperature. The vesicles were spiked with the
lipophilic ﬂuorescent probes DiIC18(5) and Bodipy-PC, and SP-B1–25 and peptoids were
ﬂuorescently tagged with Alexa Fluor® 633 carboxylic acid, succinimidyl ester. SP-B1–25
and peptoids were present in ﬁlms at ∼10 wt.%. For TL, TL+1, and TL+3, the larger
vesicle is a 3D reconstruction image, while the TL+SP-B1–25 large vesicle is from the
polar region of the vesicle. To the upper left of each large vesicle (combination image) is
the lipid-only image pane (yellow, DiIC18(5)), and to the upper right is the peptoid-only
image pane (blue, Alexa 633), except in the case of TL, for which it is BODIPY-PC pane.
Scale bars correspond to 5 μm.
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phase coexistence occurred in all lipid and lipid–peptide/toid vesicles
(Fig. 4). In the TL vesicles, rounded, gel-like, and condensed domains
were surrounded by a ﬂuid phase, whereas in TL+SP-B1–25 vesicles,
both rounded and multi-lobed condensed domains were present. The
fractal boundaries of the multi-lobed condensed domains are indica-
tive of a highly packed structure. Interestingly, the TL+1 vesicles
consisted mostly of multi-lobed, condensed domains, while TL+3
vesicles, like TL+SP-B1–25, exhibited both rounded and smaller, multi-
lobed condensed domains. In addition, the localization of SP-B1–25, 1,
and3 in theGUVswas in theﬂuid phase, as evidenced by the individual
lipid-labeled (yellow) and peptoid-labeled (blue) image panes (Fig. 4).
GUVs imaged with DiIC18(5) and ∼5 wt.% labeled SP-B1–25, 1, or 3
(Fig. 5SM) were similar to those at ∼10 wt.%, and GUVs containing
DiIC18(5) and unlabeled SP-B1–25, 1, or 3 (Fig. 5SM) exhibited similar
phase morphology to the ﬁlms containing labeled variants.
Lipid ﬁlms containing the Alexa-labeled variants incorporated into
GUVs were also assessed utilizing the PBS to ensure that surface
activity was retained after labeling (see SM for detailed results,
including Figs. 3–4SM and Tables 2–3SM). Although lowered surface
activity was noted in all mimics after labeling, the decreasing trend in
surface activity of 3N1NSP-B1–25 remained consistent.
3.5. Langmuir–Wilhelmy surface balance studies
3.5.1. Isotherm compression
To assess lipid–peptoid surface activity in a monolayer system and
compare behavior to ﬁlms containing the peptide and natural protein,
isotherms and FM images were recorded for all lipid–peptoid formula-
tions. Surface pressure (π, mN m−1)−molecular area (A, Å2 molec−1)
representativeﬁrst compression and expansion isotherms (Figs. 5 and6,
respectively) and representative FM images (Fig. 5) for TL+peptoid
ﬁlms spread at the a/l interface were obtained on a custom-built LWSB
andperformed at 25 and37 °C. For 25 °C compression isotherms and FM
images, see Fig. 6SM. The isotherm features of the TL+peptoid ﬁlms
herein were compared to TL+SP-B and TL+SP-B1–25 ﬁlms (Fig. 5,
Table 3). For mean liftoff data and 2D ﬁrst compression isotherm
features±σ, at both 25 and 37 °C, see Table 3.
For the TL+SP-B ﬁlm at 37 °C (Fig. 5, Table 3), the isotherm
exhibited a desirable early (high) ‘liftoff’ area, or the A at which π ﬁrst
measurably increases from zero. After a procession from the liquid-
expanded (LE) to liquid-condensed (LC) phases, the ﬁlm reached a
high collapse π of≥70 mNm−1 that indicates an ability to reach near-
zero γ (Fig. 5). The magnitude of the increase in liftoff A with an
additive, relative to the lipid-only ﬁlm, correlates with the molecule's
ability to crudely organize an adsorbed interfacial structure. This
effect is recognized by a measurable increase in π, and is considerably
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molecule (A). In addition, a pronounced, extended plateau occurred at
∼40–50mNm−1 in TL+SP-B ﬁlms (Fig. 5). Changes in monolayer/
multilayer structure in the plateau region are still well-debated, but
the plateau's presence is a deﬁning characteristic of SP-B- and SP-C-containing ﬁlms, and corresponds to reversible exclusion (“squeeze-
out”) of material from the monolayer into attached structures below
or above the surface. The isotherm for TL+SP-B1–25, previously
published [19–21], exhibited a later liftoff area than TL+SP-B with a
less pronounced plateau at both temperatures (Table 3), a result likely
due to the smaller size of the molecule as well as a decrease in
biomimetic behavior relative to the full-length protein.
At 37 °C, all ﬁlms exhibited a high collapse of π≥70mNm−1. The
TL ﬁlm exhibited a later liftoff and less pronounced plateau than any of
the lipid–peptoid ﬁlms (Table 3), while TL+SP-B demonstrated the
earliest liftoff and most pronounced plateau. All TL+peptoid
isotherms had earlier liftoff areas relative to the TL only ﬁlm,
indicating increased surface activity and the presence of an additive
[19,20]. The isotherm features for all three lipid–peptoid ﬁlms were
similar until the plateau region (Fig. 5). However, distinct differences
were apparent in plateau region size and shape, where TL+3 had the
most pronounced plateau, second only to TL+SP-B (Table 3). All ﬁrst
compression isotherm trends and features observed at 37 °Cwere also
apparent at 25 °C (Table 3, Fig. 6SM).3.5.2. Epiﬂuorescence microscopic imaging
Comparative insight into the 2D phase morphology and lipid–
peptoid interactions in the plateau region, relative to the peptide and
the natural protein, was obtained by recording FM images
with ∼0.5 mol% TR-DHPE spiked into the TL or TL+peptoid solution,
and are presented at ∼40 and 55mN m−1 (below and above
the plateau region), respectively, at 37 °C (Fig. 5) and ∼30 and
60mNm−1, respectively, at 25 °C (Fig. 6SM). TR-DHPE is a bulky,
ﬂuorescently headgroup-labeled lipid that is size-excluded from the
ordered phase of the monolayer upon sufﬁcient lipid packing during
ﬁlm compression. Therefore, apparent dark regions of the monolayer
correspond to liquid-condensed (LC) domains, while brighter regions
represent the disordered liquid-expanded (LE) phase. Particularly
bright spots in images signify sub- or super-monolayer protrusions of
unknown composition that are excluded from, yet still associated
with, the monolayer, known here as “bright protrusions.”
In these ﬁlms, LC domains formed at 6–7mNm−1 at 25 °C and
28–35mNm−1 at 37 °C; bright protrusions, if present, occurred at
46–48mNm−1 at both 25 °C and 37 °C. Below the plateau regime at
∼40 mNm−1 and 37 °C, the most perceptible lipid phase morphology
differences among ﬁlms were in the size of the dark LC domains
surrounded by the brighter ﬂuid LE phase (Fig. 5). The LC domains in
the TL ﬁlm were ∼58 μm2 in area, with larger LC domains for TL+SP-
B1–25 (∼75 μm2) and the other ﬁlms ranked in the order of decreasing
LC domain size 1N2N3≅SP-B. In some experimental runs, the LC
domains for 2 and 3were very difﬁcult to image due to their small size.
At ∼55 mNm−1, the TL ﬁlm retained smaller size and density LC
domains than at ∼40 mNm−1 (∼32 μm2), with the added presence of
bright protrusions residing in the LE phase. In contrast, the LC domains
in the lipid–peptoid and lipid-SP-B/SP-B1–25 ﬁlms at ∼55 mNm−1
seemed quite sparse or absent (Fig. 5). The disappearance of LCdomains
atphysiological temperature has beenpreviously observed in other lipid
ﬁlms containing aromatic peptoids [19].Fig. 5. LWSB surface pressure (π)–molecular area (A) compression isotherms and FM
images at 37 °C. π–A isotherms are representative ﬁrst compressions of a spread ﬁlm on
aqueous buffer (150 mM NaCl, 10 mM HEPES, 5 mM CaCl2, pH 6.9) with a unidirectional
barrier speed of 30 mmmin−1. Tanaka lipids alone DPPC:POPG:PA (68:22:9 [wt]) (TL,
black), TL+1 (red, circles), TL+2 (blue, squares), TL+3 (orange, triangles), and TL+SP-B
(purple, crosses). See Table 3 for isotherm 2D phase transition markers. FM images for TL
and TL+1, 2, 3, SP-B1–25, or SP-B are presented on the right at ∼40 and 55mNm−1 at
37 °C. To record images, ﬁlms were spiked with ∼0.5 mol% TR-DHPE and compressed at a
barrier speed of 5 mmmin−1. Peptoids are present at ∼2 mol% in the lipid ﬁlm, which
corresponds to∼10 wt.% SP-B1–25 relative to the total lipid content. Porcine SP-B is present
at∼1 mol% basedon themonomer composition,whichcorresponds to∼10 wt.% relative to
the total lipid content.
Fig. 6. LWSB surface pressure (π)–molecular Area (A) expansion isotherms at 25 °C (A) and 37 °C (B). π–A isotherms are representative ﬁrst ﬁlm expansions after compression to
70mN m−1 on aqueous buffer (150 mM NaCl, 10 mM HEPES, 5 mM CaCl2, pH 6.9) with a unidirectional barrier speed of 30 mmmin−1. Tanaka lipids alone DPPC:POPG:PA (68:22:9
[wt]) (TL, black), TL+1 (red, circles), TL+2 (blue, squares), TL+3 (orange, triangles), and TL+SP-B (purple, crosses).
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possibly due to interfacial SP-B protein aggregation [72], than a
typically rounded or multi-lobed lipid-only LC domain (Fig. 5). The
other signiﬁcant changes in lipid phase morphology at higher π were
evident in the bright protrusion formation and patterning, which for
TL+1, were rather clustered in aggregate-like structures, for TL+2,
weremore distinctly rounded and separated protrusions, and for TL+3,
were very bright and more evenly dispersed in round protrusions
(Fig. 5). In TL+SP-B1–25, the bright protrusions were the sparsest. The
bright protrusions in TL+SP-B were more continuously clustered
between dark regions and not identiﬁed as particularly bright and
round-shaped as in TL+3. At 25 °C (Fig. 6SM), LC domains were larger
and remained throughout the entire isotherm, as is expected given the
higher state of meso-crystallinity in the ﬁlm. In addition, at this
temperature, less brightprotrusion formationwasobserved for theTL+
SP-B1–25 and TL+SP-B ﬁlms relative to the lipid–peptoid ﬁlms.Table 3
LWSB ﬁrst compression isotherm 2D phase transition markers. Mean π–A isotherm data
from ﬁrst compressions of a spread ﬁlm on aqueous buffer (150 mM NaCl, 10 mM
HEPES, 5 mM CaCl2, pH 6.9) with a unidirectional barrier speed of 30 mmmin−1.
Standard deviation of the mean (σ) is reported. Liftoff is deﬁned as the molecular area
(A) at which the surface pressure (π) ﬁrst measurably increases from zero to
1 mN m−1.
Film 25.0±1.5 °C 37.0±1.9 °C
Liftoff Kink Plateau
length
Liftoff Kink Plateau
length
(Aa) (A) (πb) (A ) (π) (A) (A) (π) (A) (π)
TLc 84(4) 63 5 5 7 95 49 26 11 11
TL+1d 107 79 6 7 8 113 60 27 14 11
TL+2 109(3) 81 5 9 9 110 62 26 14 10
TL+3 107 79 5 10 10 116(5) 63(5) 26 17 11
TL+SP-Be 120 94 5 11(3) 10 132(5) 69 26 24(3) 12
TL+SP-B1–25 114 92 4 11 11 118(5) 64 25 13 13
σf ≤2 ≤3 ≤1 ≤2 ≤2 3 ≤3 ≤2 ≤2 1
a Mean molecular area expressed in Å2 per molecule.
b Mean surface pressure expressed in mN m−1.
c Tanaka lipid mixture, DPPC:POPG:PA 68:22:9 [wt].
d Mimics added at ∼2 mol%, equivalent to ∼10 wt.% SP-B1–25 peptide relative to the
total lipid content.
e Porcine SP-B added at ∼1 mol% based on monomer composition, roughly
equivalent to ∼10 wt.% relative to the total lipid content.
f For clarity, the standard deviation of the mean (σ) for each type of value is
collectively reported at the base of the column, with exceptions in the table listed as
“x(y),” where x is the mean and y is the σ.3.5.3. Isotherm expansion
Lipid–peptoid interactions were also monitored upon ﬁlm expan-
sion in a monolayer system, where isotherms were collected after the
ﬁrst compression to∼70 mNm−1, and are presented as representative
expansion isotherms at 25 and 37 °C (Fig. 6). At 25 °C (Fig. 6A), the TL
ﬁlm exhibited a small kink at 18±5mNm−1, while the TL+SP-B ﬁlm
had a brief “plateau region” at 44±2mNm−1 and a small kink at
23±1mNm−1. However, the TL+peptoid isotherms were similar
with very pronounced plateaus beginning at ∼25mNm−1 and ending
at ∼20mNm−1. This type of “plateau” has been suggested to be a
phase transition representing peptide reinsertion into the lipid ﬁlm
[70], and is indicative of lipid–peptoid structural reorganization at the
interface. At 37 °C (Fig. 6B), the TL and TL+SP-B expansion isotherms
were very similar to those at 25 °C. Interestingly, the pronounced
plateau in the three TL+peptoid ﬁlms at 25 °C became longer and
more gradual at 37 °C, extending from ∼43 mNm−1 to ∼ 20mNm−1,
which more closely resembled that of the TL+SP-B ﬁlm. The
reinsertion of material to the interface is critical for sustained surface
activity of the LSﬁlm [70], and itwas evident that the temperature (and
hence ﬂuidity) of the lipids signiﬁcantly affected the “plateau” shape
and thus themechanism ofmaterial reincorporation back into the ﬁlm.
3.6. Atomic force microscopy studies
Information about the lipid–peptoid interfacial mechanism of
action at the quasi-molecular level, relative to ﬁlms containing SP-B1–25,
was obtained by performing AFM on Langmuir–Blodgett lipid–
peptoid ﬁlms. The lipid phase morphologies of the lipid–peptoid
ﬁlms were characterized below and above the plateau region, 30 and
60mNm−1, respectively, by solid-supported AFM at room temper-
ature (images and height proﬁles in Figs. 7–9). Imaging of the TL ﬁlm
at 30mN m−1 (Fig. 7A) displayed a two-phase gel/ﬂuid coexistence
of both medium and large condensed-phase (LC) domains that
protruded ∼ 0.5–1.0 nm in height above the continuous,
interconnected ﬂuid (LE) phase. These ﬁndings are in good agreement
with the FM images in Fig. 6SM and previous AFMwork with a similar
lipid mixture [74]. Some LC domains appeared to be touching or
“fused,” and the boundary regions of the LC domains appeared
perforated with “holes” that were not visible in FM images (Fig. 6SM).
The TL+SP-B1–25 image at 30mN m−1 (Fig. 7A) also comprised large,
multi-lobed LC domains that were fused and protruded ∼0.5–1.0 nm
above the ﬂuid phase, but lacked the “holes” in the domain boundary
regions observed in TL ﬁlms. In addition, numerous small condensed-
phase structures (∼50–200 nm in diameter and ∼0.5–1.0 nm in
height) were observed in the ﬂuid phase of the TL+SP-B1–25 ﬁlm
Fig. 7. Atomic force micrographs and height proﬁles of TL and TL+SP-B1–25 on mica surfaces at 30mN m−1 (A) and 60mN m−1 (B) at room temperature. Tanaka lipids alone DPPC:
POPG:PA (68:22:9, wt) (TL, black) and TL+SP-B1–25 (green) monolayers spread on aqueous buffer (150 mM NaCl and 5 mM Tris, pH 7.0) were compressed to the desired surface
pressure and deposited on amica substrate for imaging. Thin white lines across each image trace the path of the height proﬁle from left to right. Boxed in areas of 10 μm-scale images
were re-imaged at the 5 μm-scale according to the lettered insets of each box. Images (left) are adjacent to corresponding height proﬁles (right).
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nanometer-scale structures were also previously observed in ﬁlms
containing DPPC:POPG:PA and dSP-B1–25 [74].
The TL+1 ﬁlm at 30mN m−1 (Fig. 8A) contained multi-lobed LC
domains, smaller than those of TL+SP-B1–25, that were sometimes
fused and also protruded ∼0.5–1.0 nm above the LE phase. Interest-
ingly, a marked increase in the number and density of small
condensed-phase structures was observed for this ﬁlm. This trend
continued afterN-terminus peptoidmonoalkylation (TL+2) (Fig. 8A),
where the large LC domains were not fused and smaller than in the
TL+1 ﬁlm, and more numerous, but smaller condensed-phase
structures were observed. In the TL+3 image (Fig. 9), the large LC
domains were yet smaller, not fused, and surrounded by innumerous
tiny condensed-phase structures throughout the ﬂuid phase.
AFM images of Survanta® (a bovine-extracted SRT) and DPPC:
POPG:PA ﬁlms were hypothesized to contain “nanosilos,” or small
pockets of clustered material (∼50–300 nm in diameter, 5–8 nm in
height) that formed above the plateau region and were believed to
trap material (POPG and/or SP-B) that would otherwise be lost to the
subphase during compression [74]. This effect was only visible when
both POPG and dSP-B1–25 were present, and we therefore hypothesizethat the small condensed-phase structures (∼1 nm in height) in the
images at 30mN m−1 represent nucleation points for the develop-
ment of nanosilos at higher surface pressures.
Above the plateau region at 60mN m−1, a height difference no
longer existed between the condensed (gel) and interconnected
(ﬂuid) phases of the TL ﬁlm (Fig. 7B), and small protrusions (∼10–
15 nm in height) in the surrounding phase ﬂanked the shape of the LC
domains in the images. In contrast, a height difference of ∼0.5–1.0 nm
between the condensed and surrounding phases of TL+SP-B1–25
persisted at 60mN m−1 (Fig. 7B), and, though the presence of many
small condensed-phase structures was visible, they did not share the
height characteristics (∼1 nm vs. ∼5–8 nm) of previously observed
nanosilos [74]. The boundaries of the LC domains also became fractal-
like for the TL+SP-B1–25 ﬁlm at 60mN m−1 (Fig. 7A).
The TL+1 ﬁlm resembled that of TL at 60mNm−1 (Fig. 8B), where
the presence of small aggregates (∼12–20 nm in height) ﬂanked the
LC domains, with no appreciable height difference between the
continuous phase and the LC domains. The nanosilo-like aggregates
also appeared to be larger in diameter than those in the TL ﬁlm.
However, in TL+2, a distinct change in patterning occurred that
resulted in two differentiated regions. Here, large, multi-lobed LC
Fig. 8. Atomic force micrographs and height proﬁles of TL+1 and TL+2 onmica surfaces at 30mN m−1 (A) and 60mN m−1 (B) at room temperature. TL+1 (red) and TL+2 (blue)
monolayers spread on aqueous buffer (150 mM NaCl and 5 mM Tris, pH 7.0) were compressed to the desired surface pressure and deposited on a mica substrate for imaging. Thin
white lines across each image trace the path of the height proﬁle from left to right. Boxed in areas of 10 μm-scale images were re-imaged at the 5 μm-scale and/or 1 μm-scale
according to the lettered insets of each box. Images (left) are adjacent to corresponding height proﬁles (right).
1673M.T. Dohm et al. / Biochimica et Biophysica Acta 1798 (2010) 1663–1678domains were surrounded by a phase containing smaller (∼2–10 nm
in height), high-density nanosilos that were more uniform in shape
than those present in the TL+1 ﬁlm (Fig. 8B).
In TL+3 (Fig. 9A), the LC domain size and shape at 30mNm−1
were mostly retained upon compression to 60mNm−1, again with no
appreciable height difference between the condensed and surround-
ing phases. Instead, two differentiated regions again persisted, with
innumerous nanosilos (∼2–8 nm) present in the surrounding phase
that were larger in diameter and present at a higher density than
those in TL+2.4. Discussion
The present work expands on the traditional approach to sequence
design of SP-B and SP-C peptidomimetic agents by incorporating
structural attributes from both proteins into one mimic. Herein, we
demonstrated that the SP-C-like N-terminus alkylation with octade-
cylamine of an aromatic, SP-B-like amphipathic peptoid helix
noticeably improved in vitro surface activity performance in a tri-
component lipid ﬁlm, likely through improved insertion ability, or
‘anchoring’ of the peptoids to the ﬁlm by the octadecyl alkyl chains.
Fig. 9. Atomic force micrographs and height proﬁles of TL+3 on mica surfaces at 30mN m−1 and 60mN m−1 at room temperature (A), and hypothesized mode of lipid–peptoid
interaction (drawing) (B). A TL+3 (orange) monolayer spread on aqueous buffer (150 mM NaCl and 5 mM Tris, pH 7.0) was compressed to the desired surface pressure and
deposited on a mica substrate for imaging. Thin white lines across each image trace the path of the height proﬁle from left to right. Boxed in areas of 10 μm-scale images were re-
imaged at the 5 μm-scale and/or 1 μm-scale according to the lettered insets of each box. Images (left) are adjacent to corresponding height proﬁles (right). In the graphic, black
circles represent DPPC, gray circles represent POPG, and white circles represent PA in the TL lipid mixture DPPC:POPG:PA 68:22:9 [wt]. The ‘insertion region’ of the peptoid helix
inserts into the interfacial lipid monolayer, with the Nocd hydrocarbon chains associating with the lipid acyl chains, and the amphipathic helix (red indicates cationic regions)
associating with the anionic lipid headgroups, sublayer lipid structures, and the aqueous buffer liquid subphase.
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structuralmotifs of SP-B andSP-C intoonemimic to enhance surfactant
formulation performance. In this work, we demonstrate that alkylated
peptoid-based SP-Bmimics substantially improved on all three criteria
considered essential to LS activity: rapid adsorption, reduction in
surface tension, and sustained surface activity through multiple
pulsation cycles, indicating that material is effectively re-spread.
The increase in surface activity of 2 and 3 relative to 1 correlated
with an increase in extent of helicity (CD) in lipid-mimetic solvent
(Fig. 2A). It is not uncommon for attachment of a fatty acid chain in
peptides to increase helicity [75,76] by increasing the helical stability
via hydrophobic chain–peptide helix interactions. Because the UV/Vis
absorbance at λ∼260 nm resulted solely from the aromatic Nspe side
chains in the peptoid helix, the decreased absorbances at λ∼260 nm
for 2 and 3 relative to 1 (Fig. 2B and Fig. 2SM, Panel B) could be similar
to that which occurs between double-stranded and denatured DNA
[77]. Alkylated peptoids may engage in intermolecular hydrophobic
interactions that facilitate intermolecular aromatic residue ‘stacking,’in turn causing peptoid self-assembly that ‘buries’ the aromatic
residues and lowers UV absorbance. These peptoid–peptoid associa-
tions may stabilize the helical motif and impart surface activity to a
surfactant ﬁlm. Assembled alkylated peptoids could collectively
anchor excluded material to the interfacial monolayer via multiple
alkyl chains, thereby increasing adsorptive properties and facilitating
re-spreading of material.
In this work, the post-alkylation ability of the lipid–peptoid
mixtures to increase the adsorption rate and promote surface tension
reduction were evaluated using the PBS. A setback in 1's surface
activity was the variable, slow adsorption rate in static-mode relative
to aliphatic peptoid variants [20]. The two-step process of LS
adsorption comprises an initial, interfacial adsorption of dispersed
surfactant, followed by ﬁlm perturbation and reorganization as new
material (ruptured liposomes) is added [78]. The adsorption rates of 2
and 3 were distinctly improved after an increase in aliphatic
hydrophobicity via alkylation, suggesting an improved two-step
adsorption rate. The hydrophobic, surface-active peptoids would be
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increased associative properties of the alkylated peptoids (as
evidenced by UV/Vis) may further facilitate rapid adsorption.
The SP-B-containing ﬁlm's seemingly slower adsorption rate could
be caused by a decrease in the rate of diffusion to the interface with
the increase in molecular size, or by possible interfacial protein
aggregation. In previous reports, a “solubility limit” of 2 wt.% was
suggested for SP-B at the interface, after which, at higher concentra-
tions, evidence of interfacial protein aggregation was observed [72].
Although no macro-scale aggregation clusters were observed during
real-time PBS bubble monitoring, strong protein associations could
have signiﬁcantly affected SP-B's behavior in this lipid system. A
peptoid concentration-dependent surface activity study will be
pursued to optimize the formulation, but for consistency in this
work, the comparison of lipid–peptoid to lipid-SP-B ﬁlms at similar
mass concentrations was useful and necessary.
Maintaining a reduced γmax throughout respiration and near-zero
γmin upon ﬁlm compression is critical for a functional LS replacement.
All lipid–peptoid ﬁlms reached near-zero γmin immediately upon
bubble pulsation, and retained this value for the time tested.
Seemingly, the importance of near-zero γmin at minimum SA is
often over-emphasized relative to a reduced γmax at maximum SA; for
instance, two surface-active peptide mimics KL4 and SP-B1–25
exhibited γmax values in the 48–50mNm−1 range in a TL ﬁlm [19].
The γmax and percent compression to reach 20mNm−1 of the ﬁlm
containing 1 were vastly improved upon alkylation, with additional
incremental improvements for mono- and dialkylation that matched
values obtained for the TL+SP-B ﬁlm, thus surpassing the surface
activity of all single helix peptide- and peptoid-based SP-B mimics
developed to date. Although the hysteresis and loop shape of
the lipid–peptoid ﬁlms appeared considerably different from that
of TL+SP-B, they coincided with a reduced percent compression that
is needed for good surfactant activity. The improved PBS activity post-
alkylation could be attributed to the increased lipid afﬁnity and
insertive ability of the alkylated peptoids, which may have aided in
retaining material at the interface for re-spreading. We further
explored this possibility by assessing lipid–peptoid interactions in
several additional in vitro assays.
SP-B and SP-C, and peptide mimics thereof, are known to reside in
the more disordered phase of a free standing lipid bilayer (GUV)
[66,79–81]. We provided evidence that this is also the case for
peptoids in a mixed lipid bilayer, supporting the idea that peptoids
play a critical role in enhancing the adsorptive and re-spreading
properties of the ﬁlm via reinsertion of excluded material from the
disordered phase. The cationic peptoid helices would likely reside in
the ﬂuid phase due to the disordered lipid packing and the anionic
character of this POPG-enriched region. In addition, lipid–peptoid
GUVs formed a gel/ﬂuid phase coexistence at 30mN m−1, and
although the signiﬁcance of variations in gel-phase domain shape of
GUVs is not yet well understood, it was visually observed that vesicles
with 3 displayed similar phase segregation patterning to those with
SP-B1–25, possessing bothmulti-lobed and rounded domains. This is in
contrast to the small rounded domains in the TL vesicles and the
predominantly multi-lobed domains of the vesicles containing 1. It
could be hypothesized that the more rigid, aromatic-rich peptoid
helix is not as well incorporated into the hydrophobic lipid acyl chains
of the bilayer, and dialkylation increases peptoid afﬁnitywith the ﬂuid
phase, thereby affecting lipid phase segregation and patterning.
Regardless, the inclusion of peptoids clearly had an effect on the
bilayer phase segregation patterning that was distinctly different in
their absence.
It should be noted that because the PBS surface activity of the
Alexa-labeled variants did not match that of the unlabeled peptide/
toids, caution must be used when making broad surface activity
comparisons. However, the observations that trends in PBS in vitro
surface activity among labeled variants remained the same asunlabeled variants, and that GUV phase morphologies remained
unchanged in the presence of unlabeled variants, provides conﬁdence
in the reliability of these measurements.
Information about the ability of peptoids to insert into interfacial
ﬁlms, to affect segregation pattern morphology, and to increase
tension-active properties were obtained through quasi-equilibrium
compression and expansion of spread ﬁlms on the LWSB and “in situ”
FM. The increased liftoff area of the SP-B-containing ﬁlm relative to
those of the lipid–peptoid ﬁlms is attributed to the sheer size of the
molecule, which is present in themixture in bothmonomer and dimer
form. The N-terminus alkylation in 2 and 3 did not signiﬁcantly alter
liftoff when compared to 1. Given that the base structural attributes of
the helix remained largely unchanged upon alkylation, this result is
strong evidence that the alkyl chains of the peptoids were well-
incorporated into the lipid acyl chains of the ﬁlm, translating to nearly
the same area occupied per molecule at the interface.
Indications of superior surface activity upon alkylation are also
present in the plateau regime (high π, low γ) of the compressed
ﬁlm, where alterations in the shape, size, and phase segregation
morphology of the ﬁlm are most evident. The very pronounced
plateau of the SP-B-containing ﬁlm demonstrates extensive
structural reorganization and 3D folding of material, in and below
the interfacial monolayer, which allows the ﬁlm to reach high π
without substantial loss of material to the subphase. Therefore, a
change in shape or increase in plateau size, as demonstrated with 2
and 3, points to an increase in biomimetic behavior relative to 1. In
addition, the decrease in LC domain size and increase in the density
of small bright protrusions in FM images further suggests
improvements in ﬁlm organization and lipid insertion ability of
the peptoids post-alkylation. Small LC domains are believed to
minimize line tension at the phase boundaries and increase the
feasibility of ﬁlm refolding and re-spreading during increases or
decreases in π, respectively.
The idea that temperature affects peptoid inclusion into the
lipid ﬁlm may be obvious given the increases in liftoff area and
plateau size at higher temperature. However, upon ﬁlm expansion,
a marked phase transition or ‘plateau’ is present in lipid–peptoid
ﬁlms at lower temperature, which does not occur when SP-B is
included. The transition may correspond to a different mechanism
of reincorporating excluded peptoid or lipid–peptoid material as
the available trough area increases; the increased bulkiness or
rigidity of the aromatic-rich peptoid helix may hinder re-incorpo-
ration at lower temperature. Surprisingly, at 37 °C, near the Tc of
the lipid ﬁlm, the lipid–peptoid expansion isotherm ‘plateaus’more
closely resembled that of the TL+SP-B ﬁlm. Because efﬁcient
reorganization and reincorporation of excluded material upon
expansion directly relates to re-spreadability, they are considered
critical features of LS ﬁlms. The considerable ‘plateau’ changes in
lipid–peptoid ﬁlms with increasing temperature suggest that SP-B-
containing ﬁlm properties may still be superior; other structural
attributes of SP-B are probably necessary in peptoids to achieve
optimal ﬁlm re-spreadability.
AFM imaging of the lipid–peptoid ﬁlms demonstrated that, above
the plateau surface tension regime, the presence of N-terminus
alkylation afforded two differentiated regions in the AFM images, one
of gel-like LC domains, and the other containing innumerous
“nanosilos” that surrounded the LC domains. Notably, at higher surface
pressure, TL+SP-B1–25 did not form nanosilos of considerable height,
which may attest to its inferior surface activity relative to full-length
SP-B. However, TL and TL+1 formed nanosilo-like structures that
were considerably higher than those previously observed for these
ﬁlms (~10–20 nm vs. ~5–8 nm in height) [74]. Interestingly, upon
N-terminus peptoid alkylation, nanosilos formed in heights previously
reported (~5–8 nm in height), and became smaller in diameter, more
densely packed, and more homogeneous in size [74]. Furthermore,
only the LC domains of TL+3 retained similar shapes and sizes to
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numerous nanosilos of moderate height, closely linked to the interface,
would be more easily reinserted upon expansion than larger, unevenly
dispersed aggregates, and it appears that N-terminus peptoid
dialkylation enhanced this effect to the largest degree. The presence
of alkylated peptoid in the ﬁlm therefore prevents one continuous gel-
like interfacial ﬁlm, with select aggregates, at higher surface pressure
(TL), and instead creates a differentiated region containing interfacial
components in the form of nanosilos. These nanosilos may improve
the re-spreading properties of the ﬁlm, allowing reinsertion of
material when expansion occurs. Our results therefore agree with
previous reports that suggest that nanosilos trap excluded material
(likely POPG and peptoid/tide) from irreversible loss to the subphase,
thus enhancing re-spreadability and ultimately increasing surface
activity [74].
Protein/peptide lipidation has been employed by Nature and
researchers to enhance biological activity [76,82–84]. Attaching a
lipid-like chain facilitates interactions with lipid membranes,
allows for intra- and intermolecular associations, and functions to
mediate protein trafﬁcking and stability. In this case, the question
to be answered is what the role of SP-C-like N-terminus peptoid
alkylation is once attached to an SP-B-like amphipathic peptoid
helix. Our hypothesis for a molecular mechanism of action is
outlined in the graphic of Fig. 9B. The alkylated chain(s) essentially
function to extend the insertion region of 1, thus ensuring that the
molecule is attached to the interface, or remains predominantly
lipid-associated. It is far-reaching to suggest that these simple
amphipathic helices completely mimic the homodimerized natural
SP-B dimer in its structure or function. The ability of these peptoids
to mimic SP-C is even less likely, as the facially amphipathic
patterning and lack of high hydrophobicity in the helix prohibit any
possibility of spanning a lipid bilayer to sustain an attached
surfactant reservoir. However, this alkylated amphipathic helix
may be capable of remaining inserted into lipid moieties,
transporting lipids to and from the interface, and in the case of 3,
connecting a monolayer and a bilayer through multiple alkylated
chain ‘anchors.’ These molecular actions would increase adsorptive
properties, reduce the surface tension, and enhance re-spreadability
of the ﬁlm.
The need for di- vs. monoalkylation was also addressed in this
study, as 3 retained a lower γmax during cycling (which was more
stable than 2, as evidenced by the decrease in σ (Table 2)), a more
pronounced plateau on the LWSB, and increased nanosilo forma-
tion resulting in two differentiated regions in AFM images, relative
to TL+2. Because a facially amphipathic helix would prefer to
associate with the lipid headgroups and aqueous subphase, it is
reasonable to speculate that dialkylation is necessary to fully
anchor the insertion region into a lipid layer. Monoalkylation could
permit conformational ﬂexibility or intramolecular associations
rather than incorporation into the lipid ﬁlm. The decreased UV/Vis
absorbance at ∼260 nm of 2 relative to 3 may be an indication of
this.
5. Concluding remarks
Ideally, the substitution of SP-B and/or SP-C in a biomimetic
formulation with a single, fully functional biomimic would result in a
bioavailable, cost-effective, and safe SRT alternative to animal-derived
material [85,86]. Thus far, the investigation into biomimicry of SP-B
and SP-C with peptoids has shown tremendous promise. We have
presented solid evidence, through multiple in vitro surface activity
tests in a tri-component lipid ﬁlm, that N-terminus alkylation
strikingly improves the surfactant activity of a single, aromatic, and
amphipathic peptoid helixmimicking SP-B by improving the insertion
ability of the peptoid into the ﬂuid phase of the lipid ﬁlm. A slight
beneﬁt in dialkylation vs. monoalkylation was also observed. Theseresults imply that a similar strategy could be employed to augment
the surface activity of single amphipathic helix peptide SP-B mimics
that have, to date, failed to be efﬁcacious enough for introduction to
the pharmaceutical market. The synthesis of such N-terminus
alkylated amphipathic helices, peptide or peptoid, is a feasible, cost-
friendly, and much preferred alternative to generating mass quanti-
ties of dimerized or otherwise structurally complex SP-B-like mimics.
We have further demonstrated that peptoid-based SP-B mimics do
generally mimic the surface activity of SP-B by substantially
improving interfacial adsorption, maintaining a reduced surface
tension, and enhancing re-spreadability of lipid ﬁlms. Further
investigations into the properties of these molecules are deﬁnitely
warranted, and cell toxicity studies and in vivo work are currently
underway for this purpose. Through these additional studies, these
functional, simple, easily synthesized, stable, and non-natural mole-
culesmay realize their full potential as surfactant proteinmimics in an
LS formulation.
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